Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma
- PMID: 6774883
- DOI: 10.1007/BF01976136
Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma
Abstract
Female Sprague-Dawley rats bearing primarily-induced mammary carcinomas were treated with a new immunostimulating agent (P 40). The histopathological modifications encountered in tumors, lymph nodes, liver and spleen are described. Intratumoral injections provoke a more widespread response of the RES, and particularly a more intense reaction in the draining lymph nodes, than systemic treatment.
Similar articles
-
The influence of dietary fat and non-specific immunotherapy on carcinogen-induced rat mammary adenocarcinoma.Vet Pathol. 1981 Jan;18(1):82-91. doi: 10.1177/030098588101800109. Vet Pathol. 1981. PMID: 6781126
-
Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapy.Int J Cancer. 2003 Dec 20;107(6):1053-7. doi: 10.1002/ijc.11501. Int J Cancer. 2003. PMID: 14601069
-
Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.Pathol Res Pract. 2017 May;213(5):441-446. doi: 10.1016/j.prp.2017.02.014. Epub 2017 Feb 24. Pathol Res Pract. 2017. PMID: 28285967
-
Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.Clin Cancer Res. 2006 Jul 1;12(13):4062-71. doi: 10.1158/1078-0432.CCR-06-0427. Clin Cancer Res. 2006. PMID: 16818706
-
A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure.Carcinogenesis. 1995 Jan;16(1):119-25. doi: 10.1093/carcin/16.1.119. Carcinogenesis. 1995. PMID: 7834796